DNA Vaccine Delivered by a Needle-Free Injection Device Improves Potency of Priming for Antibody and CD8+ T-Cell Responses after rAd5 Boost in a Randomized Clinical Trial

DNA vaccine immunogenicity has been limited by inefficient delivery. Needle-free delivery of DNA using a CO2-powered Biojector® device was compared to delivery by needle and syringe and evaluated for safety and immunogenicity. Forty adults, 18-50 years, were randomly assigned to intramuscular (IM) v...

Full description

Saved in:
Bibliographic Details
Published inPloS one Vol. 8; no. 4; p. e59340
Main Authors Graham, Barney S., Enama, Mary E., Nason, Martha C., Gordon, Ingelise J., Peel, Sheila A., Ledgerwood, Julie E., Plummer, Sarah A., Mascola, John R., Bailer, Robert T., Roederer, Mario, Koup, Richard A., Nabel, Gary J.
Format Journal Article
LanguageEnglish
Published United States Public Library of Science 08.04.2013
Public Library of Science (PLoS)
Subjects
Online AccessGet full text

Cover

Loading…